[Federal Register Volume 61, Number 124 (Wednesday, June 26, 1996)]
[Notices]
[Page 33140]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-16196]



-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE

Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on May 9, 1996, Arenol Chemical 
Corporation, 189 Meister Avenue, Somerville, New Jersey 08876, made 
application to the Drug Enforcement Administration (DEA) for 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed below:

------------------------------------------------------------------------
                    Drug                               Schedule         
------------------------------------------------------------------------
2,5-Dimethoxyamphetamine (7396)............  I                          
3,4-Methylenedioxyamphetamine (7400).......  I                          
Difenoxin (9168)...........................  I                          
Amphetamine (1100).........................  II                         
Methamphetamine (1105).....................  II                         
Methylphenidate (1724).....................  II                         
------------------------------------------------------------------------

    The firms plans to manufacture difenoxin, amphetamine, 
methamphetamine and methylphenidate to produce pharmaceutical products 
for distribution to its customers; and 2,5-dimethoxyamphetamine and 
3,4-methylenedioxyamphetamine as intermediates for the development of 
other pharmaceutical products.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, D.C. 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than August 26, 1996.

    Dated: June 18, 1996.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 96-16196 Filed 6-25-96; 8:45 am]
BILLING CODE 4410-09-M